Salvage regimens containing darunavir, etravirine, raltegravir, or enfuvirtide in highly treatment-experienced perinatally infected pregnant women

Gail F. Shust*, Jennifer Jao, Gabriela Rodriguez-Caprio, Roberto Posada, Katherine T. Chen, Amelia Averitt, Rhoda S. Sperling

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Combination antiretroviral therapy in pregnant women with human immunodeficiency virus has dramatically decreased maternal-to-child transmission. Highly treatment-experienced pregnant patients have limited effective treatment options due to past toxicities and viral resistance.We present 8 pregnancies in 7 perinatally infected women successfully treated with salvage regimens containing darunavir, etravirine, raltegravir, or enfuvirtide.

Original languageEnglish (US)
Pages (from-to)246-250
Number of pages5
JournalJournal of the Pediatric Infectious Diseases Society
Volume3
Issue number3
DOIs
StatePublished - Sep 1 2014

Keywords

  • Darunavir
  • Enfuvirtide
  • Etravirine
  • Pregnancy
  • Raltegravir

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Salvage regimens containing darunavir, etravirine, raltegravir, or enfuvirtide in highly treatment-experienced perinatally infected pregnant women'. Together they form a unique fingerprint.

Cite this